DMEA Postponed and Rescheduled for 16 to 18 June 2020

DMEA - Connecting Digital Health16 - 18 June 2020, Berlin, Germany.
The German Association of Healthcare IT Vendors (bvitg) and Messe Berlin have agreed to postpone this year's edition of DMEA - Connecting Digital Health, which will now take place from 16 to 18 June 2020. This is due to the heightened health risk and the assessment of events relating to the coronavirus (SARS-CoV-2). On Wednesday the WHO officially declared the global COVID-19 outbreak as a pandemic. Furthermore, the Berlin public health authorities have decided to cancel large events with over 1,000 participants until 19 April 2020.

"In many cases, the services of those taking part in DMEA are now required by their patients, which is why we have decided not to hold the event on the dates originally planned," said Sebastian Zilch, managing director of bvitg. "At the same time we believe that digital solutions such as video consultations and ePrescriptions have great potential to assist medical staff in these times and improve treatment for patients. DMEA is the leading platform and most important event for exchanging information on this subject."

"We are aware that the postponement creates difficulties for everyone," said Jens Heithecker, executive vice president of Messe Berlin. "However, it is the only way we can ensure the health and safety of our exhibitors, visitors and partners. By taking this decision early we can avoid a cancellation at short notice and provide greater planning certainty and security, particularly for our exhibitors."

All services previously booked, including exhibitor passes, tickets for visitors and construction passes remain valid for the revised dates in June. Additional information and FAQs can be found on DMEA website https://www.dmea.de/en/

The decision to postpone the event was coordinated with major industry partners and the partnering associations GMDS, BVMI, CIO-UK and KH-IT. DMEA looks forward to presenting a wide-ranging programme in June.

About DMEA

DMEA is Europe's leading event for health IT which gathers decision-makers from every area of the healthcare sector - including IT specialists, physicians, hospital and nursing care executives as well as experts from politics, science and research. In 2019 a total of 11,000 trade visitors came to DMEA to find out about the latest developments and products, acquire qualifications and establish important industry contacts. DMEA 2020 will take place from 16 to 18 June 2020 in Berlin. Topics will include artificial intelligence, innovations in health IT and digitalisation of nursing care processes.

DMEA is held by the German Association of Healthcare IT Vendors (bvitg) and organised by Messe Berlin. DMEA is organised in cooperation with the following industry associations: the German Association of Healthcare IT Vendors (bvitg), the German Association for Medical Informatics, Biometry and Epidemiology (GMDS), the German Medical Informatics Professional Association (BVMI). The National Association of Hospital IT Managers (KH-IT) and the Chief Information Officers of University Hospitals (CIO-UK) provide contributions on the subject matter.

Most Popular Now

Mobile App Tracking Blood Pressure Helps…

The AHOMKA platform, an innovative mobile app for patient-to-provider communication that developed through a collaboration between the School of Engineering and leading medical institutions in Ghana, has yielded positive results...

Accelerating NHS Digital Maturity: Paper…

Digitised clinical noting at South Tees Hospitals NHS Foundation Trust is creating efficiencies for busy doctors and nurses. The trust’s CCIO Dr Andrew Adair, deputy CCIO Dr John Greenaway, and...

Can AI Help Detect Cognitive Impairment?

Mild cognitive impairment (MCI) can be an early indicator of Alzheimer's disease or dementia, so identifying those with cognitive issues early could lead to interventions and better outcomes. But diagnosing...

Customized Smartphone App Shows Promise …

A growing body of research indicates that older adults in assisted living facilities can delay or even prevent cognitive decline through interventions that combine multiple activities, such as improving diet...

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...

New Study Shows Promise for Gamified mHe…

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of More Stamina, a gamified mobile health (mHealth) app designed to help people with Multiple Sclerosis (MS)...

AI in Healthcare: How do We Get from Hyp…

The Highland Marketing advisory board met to consider the government's enthusiasm for AI. To date, healthcare has mostly experimented with decision support tools, and their impact on the NHS and...

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

Patients' Affinity for AI Messages …

In a Duke Health-led survey, patients who were shown messages written either by artificial intelligence (AI) or human clinicians indicated a preference for responses drafted by AI over a human...

New AI Tool Accelerates Disease Treatmen…

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments. The tool goes beyond current artificial intelligence (AI) approaches by...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...